A detailed history of Jane Street Group, LLC transactions in Avita Medical, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 89,395 shares of RCEL stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
89,395
Previous 67,363 32.71%
Holding current value
$1.03 Million
Previous $533,000 79.74%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.72 - $10.87 $170,087 - $239,487
22,032 Added 32.71%
89,395 $958,000
Q2 2024

Aug 14, 2024

BUY
$7.92 - $15.55 $430,673 - $845,577
54,378 Added 418.78%
67,363 $533,000
Q1 2024

May 15, 2024

SELL
$12.56 - $18.31 $145,143 - $211,590
-11,556 Reduced 47.09%
12,985 $208,000
Q4 2023

Feb 14, 2024

BUY
$9.29 - $14.57 $227,985 - $357,562
24,541 New
24,541 $336,000
Q1 2023

May 15, 2023

BUY
$6.45 - $14.48 $908,488 - $2.04 Million
140,851 New
140,851 $1.97 Million
Q3 2022

Nov 14, 2022

BUY
$4.97 - $7.89 $152,822 - $242,609
30,749 New
30,749 $162,000
Q3 2022

Nov 14, 2022

BUY
$4.97 - $7.89 $152,822 - $242,609
30,749 New
30,749 $162,000
Q1 2022

May 17, 2022

SELL
$6.96 - $12.15 $127,973 - $223,402
-18,387 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$11.72 - $19.66 $215,495 - $361,488
18,387 New
18,387 $220,000
Q2 2021

Aug 16, 2021

SELL
$17.23 - $22.02 $358,900 - $458,676
-20,830 Closed
0 $0
Q1 2021

May 18, 2021

SELL
$18.38 - $28.41 $81,331 - $125,714
-4,425 Reduced 17.52%
20,830 $413,000
Q4 2020

Feb 17, 2021

BUY
$17.55 - $27.2 $443,225 - $686,936
25,255 New
25,255 $469,000
Q3 2020

Nov 17, 2020

SELL
$20.83 - $30.0 $300,889 - $433,350
-14,445 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$26.1 - $34.6 $377,014 - $499,797
14,445 New
14,445 $441,000

Others Institutions Holding RCEL

About AVITA Medical, Inc.


  • Ticker RCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,030,900
  • Market Cap $287M
  • Description
  • AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...
More about RCEL
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.